Giá của Medigene AG là bao nhiêu (MDG1)

Giá của Medigene AG (MDG1) là $0.14942078

Mũ thị trường của Medigene AG là gì (MDG1)

Giới hạn thị trường của Medigene AG (MDG1) là $3.86M

Thu nhập Medigene AG (MDG1)

Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.

Năm	Thu nhập	Thay đổi
2026 (TTM)	$-16.77M	-8.57%
2023	$-18.34M	82.41%
2022	$-10.06M	-14.01%
2021	$-11.69M	-66.20%
2020	$-34.59M	54.79%
2019	$-22.35M	-10.30%
2018	$-24.91M	60.47%
2017	$-15.53M	51.81%
2016	$-10.23M	-33.71%
2015	$-15.43M	115.69%
2014	$-7.15M	-49.32%
2013	$-14.11M	-27.68%
2012	$-19.52M	-2.57%
2011	$-20.03M	-44.87%
2010	$-36.34M	15.53%
2009	$-31.45M	-31.91%
2008	$-46.19M	0.82%
2007	$-45.82M	357.81%
2006	$-10.01M	-29.67%
2005	$-14.23M	-17.13%
2004	$-17.17M	0.00%

Năm

Thu nhập

Thay đổi

2026 (TTM)

$-16.77M

-8.57%

2023

$-18.34M

82.41%

2022

$-10.06M

-14.01%

2021

$-11.69M

-66.20%

2020

$-34.59M

54.79%

2019

$-22.35M

-10.30%

2018

$-24.91M

60.47%

2017

$-15.53M

51.81%

2016

$-10.23M

-33.71%

2015

$-15.43M

115.69%

2014

$-7.15M

-49.32%

2013

$-14.11M

-27.68%

2012

$-19.52M

-2.57%

2011

$-20.03M

-44.87%

2010

$-36.34M

15.53%

2009

$-31.45M

-31.91%

2008

$-46.19M

0.82%

2007

$-45.82M

357.81%

2006

$-10.01M

-29.67%

2005

$-14.23M

-17.13%

2004

$-17.17M

0.00%

Công ty	Thu nhập	Chênh lệch thu nhập	Quốc gia
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-31,555.72%	US
Argenx SE ARGX.US	$1.95B	-11,732.28%	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$3.01B	-18,023.94%	BE

Công ty

Thu nhập

Chênh lệch thu nhập

Quốc gia